Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial

Clinical trial NCT05382741 · UNKNOWN

Trial details

NCT number: NCT05382741
Sponsor: Ospedale Policlinico San Martino
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Stage IV No Evidence of Disease State

Start date: 2022-03-02
Primary completion: 2024-03-02
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.